iRhythm third-party application data incident

iRhythm confirmed unauthorized downloading from third-party-hosted business applications.

Last modified

Summary

  • Environment: Third-party-hosted business applications
  • Operational impact: No product or patient-safety impact identified by iRhythm
  • Financial impact: No incident cost established in the reviewed evidence
  • Record status: Developing record. Reviewed October 29, 2026; updated as evidence emerges.

What happened

iRhythm confirmed unauthorized downloading from third-party-hosted business applications. [2]

Impact

Affected data included patient identity, contact, insurance, account and device identifiers, service dates and birth dates. [2]

The South Carolina regulator’s register lists 69,526 affected South Carolina residents in the report received October 6. This is a state-specific count, not the nationwide total. [1]

The HHS breach register lists 8,179,772 individuals affected in the iRhythm Technologies, Inc. report submitted October 3, 2026. This national filing count must not be added to the South Carolina figure. [3]

Timeline

  1. Access window begins

    First date in the confirmed access window.

    [2]
  2. Access window ends

    Last date in the confirmed access window.

    [2]
  3. Patient notifications

    Notifications and the updated notice were issued.

    [2]
  4. HHS report submitted

    The HHS entry records the national affected count and submission date, separate from the June access window.

    [3]
  5. South Carolina report received

    The regulator records receipt of iRhythm’s report and its South Carolina resident count.

    [1]
  6. Briefing updated

    This briefing was last reviewed and updated on October 29, 2026.

Threat Group & Attack Vector

The reviewed disclosure does not establish the initial access method.

Actors

  • No threat actor group has been identified in the reviewed public evidence.

TTPs

  • No specific MITRE ATT&CK technique is currently mapped for this case.

Response

iRhythm investigated with external specialists and began individual notifications on October 2. [2]

It reported no identified impact to products or patient safety. [2]